Sapphire Medical Clinics and Dendrite Clinical Systems have launched the UK Medical Cannabis Registry, an initiative that is designed to rapidly expand the evidence base for medical cannabis in the UK and decrease the cost of access for patients. The launch will collect and analyse clinical information on patients taking medical cannabis treatments for all recognised eligible conditions.
“I am very pleased to report that demand for the Dendrite Web-Registry platform has reached an all-time high” Dr Peter Walton, Managing Director of Dendrite Clinical System. “We’re receiving new orders for new national and international registries every few days now – for surgical registries, medical registries, rare disease registries, medical device registries and Coronavirus Registries (for a range of Community, National, International and Global Covid-19 Registries).”
Sapphire Medical Clinics and Dendrite Clinical Systems have established the UK’s first national UK’s first comprehensive medical cannabis patient registry - UK Medical Cannabis Registry. The UK Medical Cannabis Registry will be the first of its kind covering all conditions for which there is evidence of clinical efficacy of medical cannabis. The formation of the registry means that real world evidence, cited as a key barrier to wider patient prescriptions by NHS England, will now be available on request to the medical community for analysis.
The British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), in conjunction with Dendrite Clinical Systems, is delighted to announce the release of the First UK National Flap Registry (UKNFR) Report. The UKNFR, which was launched in August 2015, collects information on all major free and pedicled flap operations carried out in the UK.
Dendrite Clinical Systems, the publisher of Bariatric News, has announced the publication of the Bariatric News Industry and Product Guide 2019 – a comprehensive A-Z guide to companies, products and services within the bariatric and metabolic specialty. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
The United Kingdom National Bariatric Surgery Registry 3rd Report (2020)
-
Code:ISBN 978-1-9160207-2-6
Published by Dendrite Clinical Systems, in conjunction with the British Obesity and Metabolic Surgery Society (BOMSS), the third iteration of the National Bariatric Surgery Registry Report builds on the previous two and includes data on an additional 38,388 patients taking the overall total to 70,461 patients. The report demonstrates the safety and effectiveness of bariatric and metabolic surgery in the UK. The report uses data from the National Bariatric Surgery Registry (NBSR), a decade long research collaboration between BOMSS and Dendrite Clinical Systems. Key highlights of the publication include:
- Bariatric Surgery procedures produced excess weight loss at one year of 73.7% after One Anastomosis Gastric Bypasses and 71.3% after Roux-en-Y gastric bypass, which compares favourably against 61.5% with sleeve gastrectomy and 38.8% with gastric banding.
- The effectiveness of surgery also reveals that the prevalence of Type 2 diabetes mellitus was reduced from 30% to 14% in the first year after surgery.
- In-hospital mortality from bariatric and metabolic surgery was very low at 0.04%, which compares very favourably with internationally accepted figures.
